IFRS 15 Revenue for the Pharmaceutical sector
IFRS 15 Revenue for the Pharmaceutical sector
IFRS 15 will change the way many pharma companies account for sales contracts.
IFRS 15 will change the way many pharma companies account for sales contracts. To help you drive your implementation project to the finish line, we’ve pulled together a list of key considerations that many pharma companies need to focus on.
© 2024 KPMG KPMG Advisors Single Member S.A., a Greece Corporation and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.